Alpha DNA Investment Management’s Philip Morris PM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-16,538
Closed -$1.99M 131
2024
Q4
$1.99M Sell
16,538
-3,053
-16% -$385K 0.76% 24
2024
Q3
$2.38M Sell
19,591
-1,235
-6% -$143K 0.89% 10
2024
Q2
$2.11M Sell
20,826
-1,337
-6% -$131K 0.82% 20
2024
Q1
$2.03M Buy
22,163
+11,535
+109% +$1.06M 0.75% 22
2023
Q4
$1,000K Sell
10,628
-8,498
-44% -$783K 0.39% 44
2023
Q3
$1.77M Buy
+19,126
New +$1.84M 0.72% 25
2021
Q2
Sell
-450
Closed -$39K 498
2021
Q1
$39K Hold
450
0.04% 206
2020
Q4
$37K Buy
+450
New +$35K 0.04% 201

Other funds holding PM

Alpha DNA Investment Management's PM Position: Q1 2025 in Review

Alpha DNA Investment Management sold out of Philip Morris (PM) in Q1 2025, closing a stake of 16,538 shares — an estimated $1.99M sold.

Alpha DNA Investment Management first reported a position in PM in Q4 2020 and held it in 8 quarters. The position peaked at $2.38M in Q3 2024. 2,708 funds tracked by Wall St. Rank hold PM as of Q1 2025.

  • Alpha DNA Investment Management reported no remaining Philip Morris position as of Q1 2025 after selling out during the quarter.
  • Alpha DNA Investment Management sold 16,538 Philip Morris shares in Q1 2025, an estimated $1.99M.
  • Alpha DNA Investment Management first reported a position in Philip Morris in Q4 2020 and held it in 8 quarters.
  • Alpha DNA Investment Management's Philip Morris position peaked at $2.38M in Q3 2024.
  • 2,708 funds tracked by Wall St. Rank held Philip Morris as of Q1 2025.

Based on Alpha DNA Investment Management's 13F filing for Q1 2025, filed 19 May 2025.